Frederick County Biotech Community

Everything Biotech in Frederick County, Maryland

Archive for September, 2008

Akonni gets another $300K in NIH Funds to Develop Protein Arrays

Posted by Jim H on September 30, 2008

According to an article in BioArray News (requires a free subscription to see the whole article):

Akonni Wins $300K NIH Grant to Move Its Dx Program Into Proteomics Arena

[September 30, 2008]

By Justin Petrone

Akonni Biosystems, a biotechnology company developing array-based tests for infectious diseases, recently won a $296,316 grant from the National Institutes of Health to steer its R&D work for the first time towards protein diagnostics, according to company officials.

Chief Scientific Officer Darrell Chandler told BioArray News last week that the grant, entitled “diagnostic protein array for respiratory infections,” is a “protein array project with the goal of being able to detect multiple pathogens in a single test.”

Chandler said that Akonni can use its TruArray platform for both protein and nucleic-acid applications, but that the NIH-funded development is “one of Akonni’s first forays into diagnostics based on a protein array approach.”

The grant brings the total NIH funds awarded to Akonni to $1.99 million. Chandler said that most of the funding helped to develop its diagnostics platform.

“The money is used in a couple of different ways,” he said. “On one hand it is used to develop specific chips or arrays from a commercial perspective; the second thing is to advance the overall platform so that arrays can be used at point-of-care or point-of-use.”

Founded in 2002, Frederick, Md.-based Akonni has set its sights on developing multiple tests for identifying pathogens that cause infectious disease. The firm’s test pipeline includes multiplex assays for detecting multi-drug-resistant tuberculosis; upper respiratory infections such as influenza A; and hospital acquired-infections like methicillin-resistant Staphylococcus aureus.

Kevin Banks, a senior marketing consultant for Akonni, said that the company plans to seek US Food and Drug Administration clearance for one of its assays within the next two years. “Our long-term plans are to build diagnostic applications that have FDA clearance in the time frame of 2010,” he told BioArray News last week.

“Our platform is general-purpose but we have been fine tuning it for specific applications for some time,” said Banks. “We haven’t specifically selected the assay; we are looking at hospital-acquired disease and infectious-disease areas and we are trying to figure out which ones we want to take through that process.”

Posted in Awards and recognition, Business, Expansion, Government Funded research, Jobs, News | Leave a Comment »

SAIC-Frederick to Bail out Fannie-Mae

Posted by Jim H on September 29, 2008

OK, well not exactly.  But I did just read a breaking story that SAIC-Frederick has won a contract valued at $5.2 BILLION US dollars (that’s like almost a million EURO).  He’s a snippet of the story.  You can read the entire press release HERE:

Sept 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ — Company to Continue Providing Operations and Technical Support to the Federally Funded Research and Development Center in Frederick, Md.

Science Applications International Corporation (NYSE: SAI) today announced that its wholly-owned subsidiary SAIC-Frederick, Inc. has been awarded a follow-on contract by the National Cancer Institute (NCI) to provide operations and technical support to NCI’s Federally Funded Research and Development Center (FFRDC) in Frederick, Md.

The single award contract has a three-year base period of performance, five one-year award-term options, and one two-year option, for an estimated contract value of $5.2 billion if all options are exercised.

The FFRDC is one of only 38 national laboratories in the United States and the only one solely dedicated to cancer and HIV/AIDS research. The FFRDC strives to develop new technologies and translate scientific discoveries into novel agents for the prevention, diagnosis, and treatment of cancer and AIDS. SAIC has been the operations and technical support contractor for the FFRDC since 1995, and in 2000 formed SAIC-Frederick to continue the work. The contract is the largest single research contract awarded by the Department of Health and Human Services.

Under the new contract, SAIC-Frederick will provide operations and technical support to the overall mission of the NCI within three major focus areas: basic research, translational research and development, and preclinical research and development. SAIC-Frederick employs more than 1,700 scientific, technical, and support personnel, and manages a comprehensive suite of cutting-edge advanced technologies in genomics, proteomics, nanotechnology, optical and electron microscopy, and high-performance biomedical computing.

Under the current contract, SAIC-Frederick supports more than 300 clinical trials, and manages a pilot program of community hospitals in 14 states studying how best to bring the latest, evidence-based cancer care to rural, inner-city, and underserved patients. It also operates two biopharmaceutical manufacturing facilities — one for NCI and the other for the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center. These facilities produce drugs, vaccines, and other biologics for use in clinical trials.

There are 50 jobs posted today on their Job Board, from Drivers and accountants through PhD Post Docs. You can see them all HERE

Posted in Business, Expansion, Government Funded research, Jobs, News, Public/Private Companies | Leave a Comment »

Going to the Birds

Posted by Jim H on September 29, 2008

I don’t know about you guys, but after SciFoo I have been getting all involved with these Web 2.0 gadgets like Twitter and Blogging (obviously), Google Groups, Wiki’s and now FriendFeed.

So much chatter going about and so many different people I met that I follow and try to keep up with what they’re doing.  Honestly, after coming back from SciFoo I was thinking about how great the experience was and how out of place I felt and how I’d just met this incredible cast of characters.  How could I follow-up on this and use these new connections to my advantage and to advance my personal agenda and make/keep new friend and extract from them some of the science they have trapped in their neurons.  It was at times and overwhelming and discouraging concept.

But then I started adding people via FriendFeed and now I am overwhelmed in a different way.  Overwhelmed by the shear magnitude of the data and stories, news, interesting papers and opinions and the freakin’ breaking edge science.  My god, I don’t know how I am going to keep up with all of this and at the same time keep my customers happy and teach my 16 year old how to drive and keep the goats fed and ready for winter and cut the grass and make sure my Fantasy Football team has the right roster in place and cultivating my Mushroom Farm to save the world….

So add to all of these distraction yet another:  Birdpost.  A sight integrating GoogleMaps with Birding.  It’s pretty simple and elegant.  You create an account and then simply chart the birds as you see them.

Yes, I know this isn’t high-tech Biotech and many of you come here to read all the latest and greatest breaking stories about this Biotech company or that.  But I had always intenbded this Blog to be interactive and I am just looking for new and creative ways to get readers to interwact with this blog.  Maybe the Birds will do it?

Like so many things, this web site is coming out of California, and the only thing I find distracting is that I have to redirect the map from San Francisco to Maryland every time.  So I hope that if a few people from Frederick sign up on this sight we can come out in force and let those guys in California know that we’re here, too. 

So sign up and start loggin your Birds onto the Map.  I need to go back and start logging in some of my Owl sightings next.

And if you don’t have a FriendFeed account, you need to create one.  It is quickly becoming a driving force in the scientific field for research collaboration and data mining.

Posted in General, Rants | Leave a Comment »

Flashback to SciFoo

Posted by Jim H on September 26, 2008

Sorry to do this again to you all, but you can tune out if you’re not interested.

I am taking a couple minutes this morning to catch up on reading some of my favorite blogs, and then ran into something new that I find fascinating.  And no, it’s not in Frederick County.  At least this may be my last reference to SciFoo for a while.  I was just reading PIMM (Attila is the one who got me into SciFoo in the first place), and followed a link out to The Edge. A Fascinating web site, to be added to my blogroll in short order.

Edge ran a story last week interviewing several celebrities that were there, George Dyson, Lee Smolin , Betsy Devine and Frank Wilczek called a Slice of SciFoo. I particularly enjoyed the phrase from Frank (we’re on a first name basis in the blogosphere, although I didn’t meet him at SciFoo):

SciFoo is a conference like no other. It brings together a mad mix from the worlds of science, technology, and other branches of the ineffable Third Culture at the Google campus in Mountain View. Improvised, loose, massively parallel—it’s a happening. If you’re not overwhelmed by the rush of ideas then you’re not paying attention.”

I am just going to copy Frank’s part, but the other sections are equally readable.

A SLICE OF SCIFOO  (from The Edge)

SciFoo is a conference like no other. It brings together a mad mix from the worlds of science, technology, and other branches of the ineffable Third Culture at the Google campus in Mountain View. Improvised, loose, massively parallel—it’s a happening. If you’re not overwhelmed by the rush of ideas then you’re not paying attention.

George Dyson’s marvelous Edge post from last year gives a lively sense of SciFoo “organization” and atmospherics.

I tried to maintain a state of controlled bewilderment, letting the experience wash over me. Now, three weeks later, a few big impressions and ideas have crystallized out. Here they come:

1. Three-Word Autobiography

SciFoo begins with a round of stylized introductions. Since 200 or so people are involved, brevity is a primary virtue. The stated mandate is: name, affiliation, three word self-presentation. Most people interpreted “word” very liberally, in the spirit of the days of Genesis, to encompass “phrase” or “topic”. I was among the happy few who literally presented themselves in three words, sat down and shut up. In the process, I discovered both a philosophy of life, an algorithm for creativity, and the title of my fictitious autobiography:

Think, Play, Repeat

Afterwards, Max Tegmark remarked that this actually packs in an infinity of words!



Max Tegmark and Frank Wilczek

2. Engines of Information

I’ve long been fascinated by the possibility of emergent (artificial) intelligence, or rather super-intelligence. While we’re not quite there yet, at Scifoo it was hard to escape the feeling that a true world-mind is nascent.

Computer scientists David Blei and Chris Wiggins advertised a session entitled “teaching a computer all of science”. The title turned out to be a little joke; what they’ve done is fed a big chunk of the journal Science into a computer, and run sophisticated artificial intelligence programs on that material, to find correlations among the words.

A sort of meaning emerges spontaneously, as clusters of words that commonly occur together indicate the existence of an underlying, unifying concept. You can—and this may be the most fascinating result so far—follow the evolution of concepts over time, as specific words enter and leave the defining clouds. (So for example the old vacuum tube technology evolves before your eyes into modern microelectronics.)

At this level, what they’ve got is a useful tool for scientists and historians. As yet the machines don’t actively seek sophisticated connections among the concepts they’ve discovered—in short, they don’t think for themselves. But just having concepts seems a big achievement, as when a baby starts to refer to things in the world with appropriate words, if not sentences.

Game developer Jane McGonical gave a brilliant presentation on the potential of the game-playing world for science, and vice versa. She points out that Wikipedia was created in approximately 108 person-hours, which is equivalent to 5 days of World of Warcraft gaming (or 1 season of American Idol voting). She says that gamers are a resource available for creative use at any task that can be reformulated as play (which covers a lot of ground!).

Astronomers have led the way in citizen science, as in the recent Galaxy Zoo project and the classic SETI@home, but McGonical envisions much more. She also wants scientists to solve society’s big problems by gaming out future world-scenarios at superstructgame.org. Looks like heavy fun.

For anyone who wants to try their hand at building organs for the world-mind, there’s now an excellent, ground-up practical introduction to the toolset: Programming Collective Intelligence by Toby Segaran. I’m getting seduced, myself.

3. The Age of Ageing

There seems to be consensus, among age researchers, that understanding and controlling the ageing process is the problem of applied biology. They would think that, of course (especially if they’re of a certain age … ), but there’s a strong objective case for it. As Aubrey de Grey and Tom Kirkwood both emphasized, curing any discrete disease (even such a big one as cancer) will make only a modest contribution to extending life expectancy (two to three years). Senescence—the general deterioration of vitality and resistance to adversity with advancing age—is the real culprit. Why does it occur? What are the prospects for slowing it?

There is a plausible evolutionary explanation, emphasized by Kirkwood. In the wild, animals do not get old—they fall victim to predators, parasites, or nasty accidents prior to senescence. Evolution favors getting in as much reproduction as possible, so it favors maximizing vitality and reproductive power during the lifespan as naturally limited by predators, parasites, and accidents. Repairs or investment in reserves that would pay off later than that are never undertaken, and senescence is the consequence.

If that’s right—and there’s considerable evidence that in essence it is—then senescence is likely to be a multifaceted complex of problems. But modern biology is powerful, and both Kirkwood and de Grey—though their short-term expectations are wildly different—argue that the time is ripe for a serious assault on those problems. For their respective takes, see Kirkwood and The End of Aging (de Grey and Rae). Given the profound importance of the problem, and the amount spent on what after all amount to relative stopgaps (e.g., curing cancer!), it’s hard to resist the argument that much more money and effort should be going into ageing research.

(An interesting specific: One way to defer senescence is well established for many animals, ranging from yeast and simple worms to mice. It is semi-starvation, also known as caloric restriction. It can make really big changes in life expectancy—a factor of two is not unheard of. Kirkwood, however, is not optimistic that it will work for humans. What seems to happen, in response to caloric restriction, is that the organism switches to a state where less metabolic energy is invested in reproduction, and more in repair. That makes evolutionary sense: in hard times, you hunker down and wait for conditions to improve, both for yourself and for your potential offspring. Normally reproductive activity is a heavy burden on mouse metabolism, so relieving it can free up significant resources. For humans, however, the burden is light.

So go ahead and eat.)

4. Planet Mushroom

Paul Stamets is—quoting Michael Pollan—”a visionary emissary from the fungus kingdom to our world”. He sees mushrooms as a replacement for chemical pesticides, a natural filter of toxins, and underground network (“nature’s Internet”) over which information flows—a primitive world-brain with vast growth potential. He also markets caps made from them. We took home a copy of his fascinating, lavish book Mycelium Running: How Mushrooms Can Help Save the World, which I’ve been enjoying immensely. (If you’ve ever had trouble with carpenter ants, you’ll savor the Schadenfreude of Chapter 8.) For a free taste of Stamets, check out http://www.youtube.com/watch?v=BelfLIJErek.

5. Space Rocks

Former astronaut Ed Lu, now a Google employee, gave a superb talk about earth-impacting asteroids. One killed off the dinosaurs, and another could have our number. Besides the rare ultra-catastrophic collision, there are much more frequent collisions that deliver punches comparable to or larger than nuclear weapons—famous ones produced Meteor Crater Arizona about 50,000 years ago and the Tunguska event in 1908. Today people are gearing up to census the potentially dangerous objects, and thinking seriously about how to divert them. Small asteroids are irregular, loosely bound clouds of rubble, not solid rocks, which complicates matters considerably. You can learn more, and perhaps choose to advance the cause, by following links from http://en.wikipedia.org/wiki/B612 Foundation.

Besides that talk about space rocks, there was a screening of In the Shadow of the Moon—a 2007 documentary about how space rocks, or rather about how the U. S. space program rocked in the 60s and 70s (hosted by David Sington, the director). It features original footage, together with interviews of the surviving Apollo astronauts. The movie is affecting on many levels: as the story of a triumphal adventure, as a portrait of unlikely young heros in their later years, as a memorial of an America familiar and yet startlingly different. I laughed, I cried, I thought. In the Shadow of the Moon is now available as a DVD, and highly recommended.

6. LHC, the Universe, and All That

I organized this hour. Brian Cox, a charismatic experimenter in high energy physics who is also a well-known BBC presenter, described the Large Hadron Collider (LHC) itself. It’s our civilization’s answer to the Pyramids of Egypt. But better: it’s a monument to curiosity, not superstition, and it’s grand scale reflects the greatness of the questions it addresses, not the vanity of its overseers. Then I discussed the issues at stake—cosmic superconductivity, unified field theory, supersymmetry— directions in which our present laws of physics beg to be improved and unified. The LHC will (finally!) give decisive verdicts about those ideas.

Turning from the very small to the very large, Max Tegmark gave us a visual tour of the Universe using http://qso.lanl.gov/pictures/Pictures.html. The Universe is pretty big, but fortunately the speed of thought is faster than the speed of light, so we got around pretty well! Martin Rees capped it off by explaining why many of us believe that the known Universe may be only a speck within a much larger Multiverse.

Our understanding of these (superficially) vastly different domains—absurdly small and ridiculously large; concrete and experimental, theoretical and speculative—is, amazingly, all of a piece. The basic laws studied at LHC tell us how the Big Bang worked. And together they encode the emerging multiverse that emerges, including its mysterious dark matter and dark energy. We’ve made dramatic progress, and the best is yet to come: it’s an exciting time to be a physicist.

Posted in bizzare, Blogterviews, Rants, Scifoo | Leave a Comment »

Advanced Technology Partnerships Initiative Moving Off the Fort

Posted by Jim H on September 25, 2008

There is a nice article in the FNP business section today about NCI hooking up with SAIC to look for a new 7.5 acre site to build a new facility to house the Advanced Technology Partnership program.

According to the Article (read the whole article HERE):

SAIC-Frederick looks for site to house partnership
Originally published September 25, 2008

By Clifford G. Cumber
News-Post Staff

A partnership seeking to deliver cutting-edge cancer research and potentially life-saving treatment more speedily to sufferers has signed its first agreements.The program, called the Advanced Technology Partnerships Initiative, was created in 2007.

Matt Zustiak, a development engineer in the Late Process Sciences group of the Biopharmaceutical Development Program, part of SAIC-Frederick Inc. at the National Cancer Institute at Frederick, operates a 1,000-liter GMP cell culture bioreactor.

Matt Zustiak, a development engineer in the Late Process Sciences group of the Biopharmaceutical Development Program, part of SAIC-Frederick Inc. at the National Cancer Institute at Frederick, operates a 1,000-liter GMP cell culture bioreactor.

The National Cancer Institute has asked SAIC-Frederick to search the county for a roughly 7.5-acre building site to house the new partnership close to the organizations’ local headquarters at Fort Detrick, said Frank Blanchard, director of public affairs with SAIC-Frederick.

The campus, expected to be commissioned by 2010, will house research and development laboratories, biopharmaceutical development facilities and office space.

NCI and SAIC are searching for partners among nonprofits, private businesses, government and academia with which to collaborate. Organizations that take part will be housed together at the campus, “with the sole goal in mind of getting cancer treatments to cancer patients sooner, and hopefully less expensively,” Blanchard said.

I also wanted to direct your attention to the following photo from Zero Gravity, taken at SciFoo in August:

Maybe you see me twice, courtesy of Photoshop, but it’s still a cool picture (click to enlarge).

Posted in Expansion, Government Funded research, Jobs, News, Public/Private Companies | 3 Comments »

Big News for New FITCI Client

Posted by Jim H on September 23, 2008

With the turnover here at FITCI that was announced in the past couple of week, I had heard about a few new people that may be moving in.

I was aware that Bob Buckheit of ImQuest fame was starting a new company and relocating to FITCI, but didn’t know all of the details.  I came across this press release today:

Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer

FREDERICK, Md., Sept. 23 /PRNewswire/ — Arisyn Therapeutics Inc. (Arisyn) announced today day that it has successfully acquired from UAF Technologies and Research, L.L.C. (UTR) a series of highly novel small molecule inhibitors with a well-defined preclinical efficacy spectrum against a variety of infectious organisms and cancer. Under the terms of the assignment, Arisyn will assume the intellectual property portfolio. In return, UTR will receive a cash assignment fee, cash payments on the achievement of certain defined milestones and royalties on future sales of derivative drugs.

The assets involved in the transaction include molecules originally developed by The Proctor and Gamble Company, which were donated in 2003 to UTR for research at the University of Arizona. The therapeutic agents which constitute the portfolio target the replication of the human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV-1), hepatitis C virus (HCV), influenza virus, herpes viruses, and also include broad based inhibitors of cancer. Lead compounds from the series for HIV and cancer have already been tested in Phase 1 human clinical trials, while a lead inhibitor of HCV has progressed to the submission of an IND application with the FDA. The compounds inhibit virus replication by a highly unique mechanism of action involving inhibition of viral RNA transcription and have been found to be safe inextensive toxicological evaluations.

“These novel inhibitors form the basis of a new strategy to treat infectious disease by targeting a critical viral replication pathway within the infected cell and turning off the production of progeny infectious virus. The therapeutic agents should be highly effective additions to the combination therapy regimens currently used to treat infectious disease and of immense benefit to the millions of individuals chronically infected with organisms such as HIV and HCV,” noted Robert W. Buckheit, Jr., Ph.D., Director of Research and Development for Arisyn. “The compounds have proven efficacy and safety in preclinical studies and have shown significant promise to progress to Phase 1 human clinical trials for the treatment of HIV and cancer.”

The continued preclinical and clinical development of the compound portfolio will be performed by ImQuest BioSciences, a Contract Research Organization located in Frederick, MD specializing in the development of drugs for the treatment of infectious disease and cancer. ImQuest will perform necessary preclinical and clinical studies and manage the evaluation of Arisyn’s compounds in human clinical trials, as well as assist Arisyn with the discovery of next generation inhibitors of the novel therapeutic targets.

Bo Statham, UTR Manager, said he is very pleased that this promising technology has been assigned to Arisyn, a company that will focus exclusively on the development of these drugs.

Posted in Business, Expansion, News, Public/Private Companies | Leave a Comment »

IBT and Statistics

Posted by Jim H on September 18, 2008

I read on Tedco’s web site that Integrated BioTherapeutics (ok, they’re in Germantown, but I know most of the guys that work there live in Frederick and they just moved out of the incubator in the spring) won another MTTF grant for $75K

According to the press release:

Integrated BioTherapeutics, Inc., located in Germantown, Md., is working with
University of Maryland College Park to develop a multivalent vaccine against three
toxins produced by Staph bateria: SEB, SEA and TSST-1. The ultimate goal is to use the
vaccine to develop hyperimmune human antibodies in healthy individuals to be used as
therapeutics for toxic shock syndrome and to test its efficacy in hospital acquired
infections.

Tom Fedor/The Gazette
BioStat Solutions, led by Ronald and Ena Bromley, plans to move to downtown Mount Airy this fall. Behind them are (from left) employees Angela Prokop, Doris Westhoff, Jared Kohler, John Seibel and Karen Ellingson.

And also from the Gazette comes the news that BioStat Solutions will be moving into one of the buildings that was destroyed by fire in downtown Mt Airy.

BioStat Solutions, a statistical consulting company, will be moving to 114 Main St., becoming the largest tenant in the new building there. The move is expected in early November. The new building encompasses both a renovation of the nearby Bohn Building, which was destroyed in the downtown fire a year ago, and a previously planned project on an adjacent lot.

BioStat Solutions, whose revenues have grown 22 percent this year, offers three main services: analytical expertise in pharmacogenetics, the study of how drugs affect people based on their biological inheritance; statistical analyses for clinical studies; and custom databases for biological applications and managing clinical trial and research data.

Posted in Awards and recognition, Business, Expansion, Government Funded research, News | Leave a Comment »

News of Note

Posted by Jim H on September 16, 2008

Some days, or weeks, I scan every available avenue looking for some interesting FredCoBio news for even a morsel to blog about.  This morning I’ve seen so many stpries that I have a weeks worth of stories, but I’ll jam them all into one post and maybe expand on them later.

The first story I saw this morning was from by Alex Philippidis at BioRegion News:  “Maryland Gearing Up to Build New $91.5M Life-Sci Economic Development Agency.” You’ll have to register for a “free subscription” to read it in it’s entirety (just need to give them your e-mail) because it’s too long to post the whole thing here.  The article is an excellant review of everything happening with the MBC, as I blogged last week.  Stealing a few lines from the article (which you should really read for yourself):

The new Maryland Biotechnology Center will be designed as “a one-stop shop” linking life sciences employers to economic incentives, business assistance, and other state services, Lawrence Mahan, senior strategic advisor for biotechnology with the state Department of Business and Economic Development, told BioRegion News last week.

In a revised DBED organization chart distributed to employees and available here, the agency said the biotech center will be “designed to assist bio entrepreneurs, fund life-sciences research, develop bio curricula and provide workforce and education training grants.

I am still trying to figure out if this facility is built or is being built and if so, where? I saw a large, vacant facility last week when i was in Germantown on 28, west of G’burg. Maybe that was it?  I am pretty certain that they won’t stick it in Frederick, but maybe they could settle for Urbana?  Urbana is almost like MoCo North anyway.

In another article that caught my eye, a team from the Scripps Institute has developed a novel method to identify pluripotent stem cells—cells that can differentiate into multiple distinct cell types-based upon transcriptional phenotypes.  The paper, entitled “Regulatory networks define phenotypic classes of human stem cell lines“, appears in this months Nature.  You can read the abstract in Nature, but I can promise you there’s no “free subscription” to Nature.

The big news here is that one author is Invitrogen’s own (and formerly SABiosciences) Mahendra S. Rao.  He even lists his corresponding address as ” Invitrogen Co, 3705 Executive Way, Frederick, Maryland 21704, US”.  I know IVGN has a big push on Stem Cells and Regnerative Medicine, but I still think a lot of that is going on in Carlsbad.  Not sure, so if anyone knows, please let me know.

In any event, this is a major undertaking and is really good for advancing Stem Cell research.

And last, but not least, I was very happy to see this article in Yahoo!Finance:

International Stem Cell Corporation Announces a Manufacturing and Supply Agreement with Millipore Corporation
Tuesday September 9, 9:30 am ET

OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell (OTCBB:ISCO – News) announced today it has entered into a worldwide distribution agreement with Millipore Corporation (NYSE: MIL – News) to manufacture living cells and cell culture products to be sold through Millipore’s distribution network.

“To work with a company such as Millipore that has sales of over $1.5 billion and is known throughout the world is a wonderful opportunity for ISCO. This partnership will lead to a significant expansion in ISCO’s revenue generation through the manufacture of high quality cells and cell culture products. Millipore is a leader in the life science industry, with a strong sales force and distribution network serving biotechnology firms, pharmaceutical companies and laboratories around the world. The ISCO-Millipore team will provide valuable research tools for cell biologists across the world,” according to Jeffrey Janus, ISCO’s president.

International Stem Cell, an emerging stem-cell therapy company, is the first company to perfect a method of creating human stem cells from unfertilized eggs. These cells, called “parthenogenetic” stem cells promise to alleviate two critical problems inherent in cell transplantation today, immune rejection and the ethical issues associated with the use of fertilized human embryos. ISCO, through its wholly-owned subsidiary, Lifeline Cell Technology (Walkersville, MD) develops and manufactures cell culture products for research use. Such manufacturing generates revenue and therapeutic production capacity for ISCO.

“We are very excited about driving our partnership forward with ISCO,” said Don O’Neil, Millipore’s Director of Marketing for Stem Cells. “With this relationship, Millipore gains access to a world class team of scientists responsible for developing many of the ‘first-in-class’ specialty media products on the market. The ISCO offering perfectly compliments our strategy to become the industry leading specialty and stem cell culture complete solutions provider.”

Again, just more news from California? No, not really. Remember when I told you that the Universe doesn’t revolve around California?  Most of the work is going to be done in Walkersville and LifeLine.  The California side of ISCO is where the Goldminers are.  They’re working with the parthenogenic SC’s on therapeutics and Regenerative Medicine.  The Hardy soul of the company is in the facility in Walkersville, where they’re making the medium and cell lines and doing a lot of the testing.  So it looks like their facility might be hiring some more people to keep up with the Millipore orders.

And I just heard from Judy at Neuronascent (whom I’ve told people before shares space with LLCT in Walkersville) actually hired a part-time person who responded by follwoing the add I posted for her on this blog! Wow, maybe I should move into the recruiting business….

Posted in Business, Expansion, Government Funded research, Jobs, News, Public/Private Companies, Rants, Stem Cells | Leave a Comment »

Monday Funnies

Posted by Jim H on September 15, 2008

I was surfing through my blogroll this morning and came across a funny little comic on Ouroboros I thought you would enjoy:

Ouroboros borrowed these comics from Alexander Dent on his blog Dent Cartoons.  There are tons of funny comics on his site. Here are a couple few more (click to enlarge in high resolution):

Posted in bizzare, Funny | Leave a Comment »

Leaving the Nest

Posted by Jim H on September 12, 2008

A feature article in yesterday’s Gazette is about a number of companies leaving the Incubator known as FITCI to start their own empires.  Most of these I have already blogged about, but some new news in the story.

Tom Fedor/The Gazette Maureen Gearheart of Histo-Scientific Research Laboratories digitizes bone imagery in the company's lab at the Frederick County incubator. The company is one of a half-dozen graduating from the facility.

The new graduates are Integrated BioTherapeutics Inc., Imagilin Technology, Cybrdi Inc., APE-BridgePath, Histo-Scientific Research Laboratories Inc. and ChromoTrax.

IBT was the first to depart the incubator, moving (sadly) to Montgomery County in June.  They had momentum from the start, winning TEDCO funding and then an SBIR grant.  Javad also had some good contacts from his work at USAMRIID, pictured below with my old boss Paul Silber, receiving the Incubator Company of the Year Award (in June).

My old friend JJ Lin (by “old” I mean I have known JJ for almost 20 years now. Come to think of it, that would make him and old man by now) and Imagilin are moving from FITCI@Hood to Potomac (another one moving to Montgomery County).

Larry Liu and Cybrdi are in the process of setting up shop in Gaithersburg.  I actually had a meeting with him ealry this week to discuss some potential collaborations.

I have been working closely with Joe & Patrick at APE-BridgePath for the past two years.  They have been developing their business while renting warehouse space out by the airport and sharing space at Akonni to refurbish equipment.  Leveraging the proceeds of a couple nice CRO contracts for recombinant protein production and a installing refurbished lab equipment at the new Lentigen facility, they are going to consolidate into a single facility here in Frederick.  Bhavesh and Dana (pictured on right) may actually have enough room to stay out of my space, for a change.  Perhaps we’ll see the ribbon cutting ceremony in the paper sometime this fall?

HSRL bought an old bowling alley in Thurmont and are awaiting the conversion into a histology laboratory.  Here at FITCI, they’re primarily making the parrafin embedded slides.  You can tell because there is a trail of wax between their two labs thats permeated the carpet.  All that wax is a much better fit for a bowling alley than our carpeted halls.

The article also says that Chromotrax may be moving in with APE-BP this fall.  I knew they were working on a project with DNA FISH probes and had recieved some funding, so I guess it was inevitable that they’d be leaving the nest.

So FITCI is poised for a turnover of the labs, both at Monocacy (where I am) and at Hood.  There has been a steady flow of people in our facility looking at space, and a few new faces occupying offices already.  Should be an interesting fall season for Frederick County Biotech!

Posted in Awards and recognition, Business, Expansion, News, Rants | Leave a Comment »

 
Follow

Get every new post delivered to your Inbox.